ZKIN vs DLPN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

ZKIN

57.6
AI Score
VS
ZKIN Wins

DLPN

47.4
AI Score

Investment Advisor Scores

ZKIN

58score
Recommendation
HOLD

DLPN

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZKIN DLPN Winner
Forward P/E 0 19.6078 Tie
PEG Ratio 0 0 Tie
Revenue Growth -43.5% 2.5% DLPN
Earnings Growth -97.7% -70.2% DLPN
Tradestie Score 57.6/100 47.4/100 ZKIN
Profit Margin -5.6% 0.0% DLPN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ZKIN 1M: -20.4% · 3M: -25.0% DLPN 1M: +3.8% · 3M: -9.8%

Current Technical Phase

ZKIN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.0%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $1.11

DLPN

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.7%) with fading momentum, RSI 47

RSI (14): 47.3 · Price: $1.10

Fundamentals Snapshot

Metric ZKIN DLPN
Market Cap
Forward P/E 0.0 6.9
Trailing P/E
Revenue (TTM)
Revenue Growth -0.4% 0.0%
Gross Margin 0.1% 1.0%
Operating Margin -0.1% -0.1%
EPS -0.71 -0.27
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZKIN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.